Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Agnosia × Ibuprofen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Pain 3 Cachexia 3 Breast Neoplasms 3 Trigger Finger Disorder 2 Prostatic Neoplasms 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Inflammation 2 Ganglion Cysts 2 De Quervain Disease 2 Colorectal Neoplasms 2 Weight Loss 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Supratentorial Brain Tumor 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatitis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pituitary Neoplasms 1 Patient Satisfaction 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nose Neoplasms 1 Neoplasm Metastasis 1 Mucositis 1 Menorrhagia 1

Interventions

Bupivacaine 11 Ketamine 9 Ropivacaine 8 Morphine 8 Acetaminophen 8 Fentanyl 7 Dexmedetomidine 7 Lidocaine 6 Anesthesia, General 6 Analgesics, Opioid 6 Saline Solution 5 Anesthesia, Local 5 Acupuncture Therapy 5 parecoxib 4 Tramadol 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Analgesia, Epidural 4 Radiofrequency Ablation 3 Propofol 3 Oxycodone 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Therapeutics 2 Surveys and Questionnaires 2 Magnesium Sulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡